MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma

MediPharm Labs Corp. LABS MEDIF MLZ will extend its supply deal with Europe-based medical cannabis company ADREXpharma GmbH.

The Toronto-based company entered into a private label sales agreement for exports to Europe with the German licensed distributor of medical cannabis and controlled drugs in 2019.

Since then, MediPharm has been providing ADREXpharma with THC and CBD products for sale and distribution under the ADREXpharma brand in Germany.

The deal was renewed for five years, with an option for further extension.

MediPharm And Medical Cannabis Market In Germany

MediPharm boosted its presence in Germany by agreeing to supply GMP-certified medical cannabis products to pharmaceutical giant Stada Arzneimittel AG last year and by inking a two-year supply agreement with IM Cannabis’s IMCC IMCC subsidiary, Adjupharm GmbH in April.

Over the first quarter of 2021, the company finalized its first shipment of cannabis products to ADREXpharma and is poised to deliver the next one in the second quarter.

“With our global platform purpose-built to good manufacturing practices, MediPharm has established a strong foothold in the nascent, but burgeoning, German cannabis market,” Keith Strachan, president and Interim CEO of MediPharm, said Tuesday. “Our collaboration with ADREX has been an important and strategic step in our growth in this attractive market. We will continue to work together, combining ADREX’s experience and local networks with our licenses, production, and supply chain capabilities, to ensure German patients gain access to the high-quality cannabis products they can trust.”

As the largest medical cannabis market in Europe, Germany's patient base has grown to 128,000, the company reported, which led to a 34% increase in medical cannabis sales in 2020.

Mario Eimuth, a founding partner at ADREXpharma, said they are “excited having launched the first products produced by MediPharm in the growing German market and to expand our international footprint with this strategic collaboration.”

Photo by Esteban Lopez on Unsplash

Posted In: CBDKeith StrachanMario EimuthCannabisNewsPenny StocksMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.